Breaking News

Thermo Fisher Scientific Launches New SmartRaman+ Spectrometer

The DXR3 SmartRaman+ is designed to detect defects or contaminants while preserving sample integrity.

Thermo Scientific DXR3 SmartRaman+ Raman Spectrometer

Thermo Fisher Scientific has launched the Thermo Scientific DXR3 SmartRaman+ Raman Spectrometer for at-line quality control analysis across pharmaceutical and industrial environments. The system combines non-destructive Raman spectroscopy, automated sampling and custom sample holders and is designed to allow for accurate testing through final product containers without compromising sample integrity. 

The DXR3 SmartRaman+ is designed to detect defects or contaminants while preserving sample integrity, supporting more confident decision-making and helping to safeguard product quality from early production through final packaging.  

QC testing can be a labor-intensive process, requiring diligent sample analysis and robust documentation to comply with industry regulations. According to the company, the system delivers faster QC workflows than traditional techniques and reduces the time required for operator training, with easy-to-use hardware.  

“The DXR3 SmartRaman+ is designed to bring confidence and efficiency to quality control workflows,” said Ganesh Prasad, General Manager for Vibrational Spectroscopy Products, Thermo Fisher Scientific. “By combining non-destructive Raman analysis with automated sampling and intuitive operation, it helps teams detect contaminants faster, reduce sample waste, and is designed to ensure consistent product quality across pharmaceutical and industrial manufacturing.” 

Supporting both 532 nanometer (nm) and 785 nm laser wavelengths, the DXR3 SmartRaman+ Spectrometer enables flexibility in the laboratory, delivering the analysis of various sample types including liquids, powders and finished packaged goods.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics